טוען...
Bi-directional drug-microbiome interactions of anti-diabetics
Type 2 diabetes (T2D) has become a global epidemic. Although several drugs are available to manage T2D, problems associated with person-to-person variability in drug efficacy and potential side-effects remain unresolved. Owing to the emerging role of the gut microbiome in obesity and T2D, the intera...
שמור ב:
| הוצא לאור ב: | EBioMedicine |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6354569/ https://ncbi.nlm.nih.gov/pubmed/30553752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.11.046 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|